ArticleMolecular biology reports2026
ALKBH5-regulated circ_0032649, acting as a sponge for miR-4755-3p to upregulate ORAI2, facilitates intrahepatic cholangiocarcinoma tumorigenicity.
Yi Tang, Qiuhuan Zhang, Xuanchao Wen, Rongjun Liu, Shaowei Xie, Bin Chen, Tao Huang, Xiang Huang, Dongyi Xie, Wei Huang and 2 more
Abstract read
In one paragraphArticle in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Yi Tang *Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0000-0001-7658-870X Qiuhuan Zhang *Department of Colorectal and anal surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0000-0003-1418-187X Xuanchao Wen *Department of Colorectal and anal surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0007-8088-2793 Rongjun LiuDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0004-1753-2553 Shaowei XieDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0000-0002-5237-128X Bin ChenDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0009-8332-9840 Tao HuangDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0000-8101-0742 Xiang HuangDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0003-7291-8136 Dongyi XieDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0009-0003-4779-264X Wei HuangDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China.ORCID http://orcid.org/0000-0001-9239-8893 Zhenyong TangDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China. 164825120@qq.com.ORCID http://orcid.org/0000-0001-6348-8427 Yuntian TangDepartment of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, China. tytshl2000@aliyun.com.ORCID http://orcid.org/0000-0003-4267-935X Funding
National Natural Science Foundation of China 82260558the Natural Science Foundation Project of Guangxi 2025GXNSFAA069067
6 · The paper itselfAbstract
objectiveCircular RNAs (circRNAs) serve as critical biomarkers in intrahepatic cholangiocarcinoma (ICC). This study aimed to identify the key circRNA targeted by ALKBH5 in ICC and elucidate the underlying molecular mechanisms. METHODS AND
resultsSixteen clinical samples were collected to assess ALKBH5 expression pattern in ICC. CircRNA sequencing was performed to identify the key circRNA targeted by ALKBH5, followed by bioinformatic prediction of the associated microRNA and downstream mRNA. Following in vitro transfection, cell functions were evaluated using cell counting kit-8, colony formation, and flow cytometry. Molecular interactions were assessed by RNA immunoprecipitation and dual-luciferase reporter assays. A xenograft tumor model was established, followed by intratumoral injection of lentivirus, to assess the tumorigenic capacity of ALKBH5 and circ_0032649. The results indicated that ALKBH5 was significantly overexpressed in ICC tumors compared with paracancerous tissues. Circ_0032649 was identified as a key downstream circRNA of ALKBH5 to mediate the expression of the miR‑4755‑3p/ORAI2 axis. Depletion of ALKBH5 significantly suppressed ICC cell viability, colony formation, apoptosis resistance, and epithelial-mesenchymal transition, while inducing G1-phase cell cycle arrest. Mechanistically, ALKBH5 bound circ_0032649, which functioned as a sponge for miR-4755-3p to upregulate ORAI2 expression. In vivo, the ALKBH5/circ_0032649 axis similarly promoted ICC tumor progression and altered the expression of this competing endogenous RNA (ceRNA) regulatory axis.
conclusionALKBH5-regulated circ_0032649 promotes ICC malignancy by a miR-4755-3p/ORAI2-dependent ceRNA network.
Indexed as
AlkB Homolog 5, RNA DemethylaseBile Duct NeoplasmsCholangiocarcinomaMicroRNAsRNA, CircularAnimalsApoptosisCarcinogenesisCell Line, TumorCell ProliferationEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHumansMaleMiceALKBH5 protein, humanAlkB Homolog 5, RNA DemethylaseMicroRNAsRNA, CircularRNA, Competitive EndogenousALKBH5circ_0032649Circular RNA sequencingCompeting endogenous RNAIntrahepatic cholangiocarcinomamiR-4755-3pORAI2
What OpenQuestion holds
Textmetadata
Read underepoch 390